Skip to main content

Molecular Imaging in Oncology: Hybrid Imaging and Personalized Therapy of Cancer

  • Chapter
  • First Online:
  • 1652 Accesses

Abstract

It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner. However, the utilization of telomeres in clinical practice for patient evaluation is still in the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of molecular imaging (MI) in the evaluation of oncologic patients.

(Diagnosis—Staging—Response to Therapy—Restaging of the Tumors).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Massoud TF, Gambir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5):545–580

    Article  CAS  Google Scholar 

  2. Gambir SS (2008) Molecular imaging of cancer: from molecules to humans. J Nucl Med 49(Suppl 2):1–4

    Article  Google Scholar 

  3. Wagner HN Jr (2006) A personal history of nuclear medicine. Springer, London

    Google Scholar 

  4. Vallabhajosula S, Solnes L, Vallabhajosula B et al (2011) A broad overview of PET Radiopharmaceuticals and clinical applications: what is new? Semin Nucl Med 4:246–264

    Article  Google Scholar 

  5. Homer Macapinlac (2011) MI in clinical oncology (imaging guided personalized therapy): iiCME: multimodality imaging: PET/CT and SPECT/CT

    Google Scholar 

  6. Wistuba II, Gelovani JG, Jacoby JJ et al (2011) Methodological and practical challenges for personalized cancer therapies. Nat Rev Clin Oncol 8(3):135–141

    Article  CAS  Google Scholar 

  7. Sohn HJ, Yang YJ, Ryu JS et al (2008) Clin Cancer Res 14:7423–7429

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George N. Sfakianakis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sfakianakis, G.N. (2018). Molecular Imaging in Oncology: Hybrid Imaging and Personalized Therapy of Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68873-2_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68872-5

  • Online ISBN: 978-3-319-68873-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics